DCGI Approves BE’s 14-Valent Pneumococcal Conjugate Vaccine
Press Releases (Dcgi)
-
-
CORBEVAX gets DCGI Nod as a Heterologous COVID-19 Booster Dose
-
National Regulator approves “Conditional Market Authorization” of two COVID19 Vaccines- Covaxin and Covishield
-
Sun Pharma receives DCGI approval for MolxvirR (Molnupiravir) in India
-
CORBEVAXTM gets Drugs Controller General of India approval
-
Hetero's Biosimilar version of Tocilizumab receives emergency use authorization from DCGI
-
Zydus applies to the DCGI for EUA to launch ZyCoV-D
